Silencing a deadly conversation in breast cancer
While it is already known that breast cancer cells create the conditions for their own survival by communicating their needs to the healthy cells that surround them, Australian researchers have identified a new way of turning off that cellular cross talk. They have shown that a molecule known as 'hedgehog' sits at the centre of the switchboard in breast cancer, transmitting biochemical signals between the cancer cells and healthy cells.
When this conversation is blocked – or hedgehog is 'silenced' – tumours shrink and stop their spread.
While the finding applies to all breast cancers, it is particularly relevant for women with basal breast cancer, for which there is no current targeted therapy.
The good news is that drugs for silencing hedgehog are already undergoing Phase 2 clinical trials in other cancer types.
Clinical Associate Professor Sandra O'Toole and Dr Alex Swarbrick, from Sydney's Garvan Institute of Medical Research, analysed breast tumour samples from a cohort of 279 women with advanced breast cancer, revealing that the higher the level of hedgehog, the more aggressive the cancer.
Having discovered high levels of hedgehog in some breast cancer patients, they went on to over-produce the protein in mouse models of basal breast cancer. Mice developed tumours that grew and spread through the body rapidly. When hedgehog was blocked, the tumour growth and spread were significantly slowed.
These findings are published in the prestigious international journal Cancer Research, now online.
"We are hopeful that our findings will drive the progress of clinical trials for anti-hedgehog drugs in breast cancer," said Dr Alex Swarbrick.
"Finding an effective drug target for basal breast cancer is a very high priority. It is often referred to as 'triple negative disease', because it doesn't produce any of the oestrogen, progesterone or HER2 receptors, targets of the drugs tamoxifen and Herceptin, which are very effective in other breast cancers."
A/Prof O'Toole, also a pathologist at Sydney's Royal Prince Alfred Hospital, undertook the study as part of her PhD. "These findings may provide some hope to the many women who succumb to breast cancer each year, especially the basal sub-type, although obviously it is early days," she said.
"More work in animal models is needed to understand exactly how best to block this pathway."
"Our study demonstrates that starving breast cancer cells of hedgehog significantly slows their growth and spread."
Source: Research Australia
Articles on the same topic
- Breast cancer drug pushes colon cancer cells to their deathWed, 8 Jun 2011, 19:39:17 UTC
- Mayo Clinic, NCCTG find no tie between PTEN and response to breast cancer drugSun, 5 Jun 2011, 1:02:42 UTC
- Hormone deprivation therapy for prostate cancer may raise diabetes riskSat, 4 Jun 2011, 19:03:41 UTC
- Obesity raises breast cancer survivors' risk of dying of the cancerSat, 4 Jun 2011, 19:03:30 UTC
- Fetal programming of disease risk to next generation depends on parental genderSat, 4 Jun 2011, 19:03:21 UTC
- UB played major role in study on drug that reduces breast cancer in high-risk womenSat, 4 Jun 2011, 17:32:33 UTC
- Breast cancer surgery patients benefit from adding radiation therapySat, 4 Jun 2011, 16:02:44 UTC
- ASCO: Emerging trends in radiation therapy for women over 70 with early stage breast cancerThu, 2 Jun 2011, 21:36:43 UTC
Other sources
- Breast cancer drug pushes colon cancer cells to their deathfrom Science DailyWed, 8 Jun 2011, 19:30:31 UTC
- Breast cancer drug pushes colon cancer cells to their deathfrom PhysorgWed, 8 Jun 2011, 18:30:38 UTC
- Drug prevents some breast cancersfrom Sciencenews.orgTue, 7 Jun 2011, 15:40:09 UTC
- Drug prevents some breast cancersfrom Sciencenews.orgTue, 7 Jun 2011, 14:20:10 UTC
- Breast cancer drug with fewer side effects found to cut risk of tumorsfrom LA Times - HealthMon, 6 Jun 2011, 19:30:23 UTC
- Hormone test predicts ovarian function after chemotherapy for breast cancerfrom Science DailyMon, 6 Jun 2011, 17:30:39 UTC
- Drug prevents breast cancer in some women: studyfrom CBC: HealthSun, 5 Jun 2011, 1:00:13 UTC
- Breast cancer drug with fewer side effects found to cut risk of tumorsfrom LA Times - ScienceSun, 5 Jun 2011, 0:00:28 UTC
- Drug prevents breast cancer in some women: studyfrom CBC: Technology & ScienceSun, 5 Jun 2011, 0:00:18 UTC
- Breast cancer surgery patients benefit from adding radiation therapy, study suggestsfrom Science DailySat, 4 Jun 2011, 23:30:26 UTC
- Obesity raises breast cancer survivors' risk of dying of the cancer, study findsfrom Science DailySat, 4 Jun 2011, 23:30:21 UTC
- Exemestane reduces breast cancer in high-risk women, researchers showfrom Science DailySat, 4 Jun 2011, 23:30:19 UTC
- Breast cancer drug with fewer side effects found to cut risk of tumorsfrom LA Times - HealthSat, 4 Jun 2011, 20:00:15 UTC
- Obesity raises breast cancer survivors' risk of dying of the cancerfrom PhysorgSat, 4 Jun 2011, 19:00:23 UTC
- Hormone-blocking drug reduces breast cancer riskfrom PhysorgSat, 4 Jun 2011, 18:00:18 UTC
- Estrogen blocker cuts breast cancer risk 65%: studyfrom PhysorgSat, 4 Jun 2011, 18:00:16 UTC
- Breast cancer surgery patients benefit from adding radiation therapyfrom PhysorgSat, 4 Jun 2011, 17:30:20 UTC
- UB played major role in study on drug that reduces breast cancer in high-risk womenfrom PhysorgSat, 4 Jun 2011, 17:30:19 UTC
- Study confirms long-lasting anticancer benefit of zoledronic acid for women with early-stage breast cancerfrom PhysorgFri, 3 Jun 2011, 23:30:35 UTC
- No tie found between PTEN and response to breast cancer drug herceptin, according to new studyfrom Science DailyFri, 3 Jun 2011, 23:30:28 UTC
- Emerging trends in radiation therapy for women over 70 with early stage breast cancerfrom PhysorgThu, 2 Jun 2011, 21:30:36 UTC
- Emerging trends in radiation therapy for women over 70 with early stage breast cancerfrom Science DailyThu, 2 Jun 2011, 21:30:18 UTC
- Silencing a deadly conversation in breast cancerfrom Science DailyThu, 2 Jun 2011, 14:30:29 UTC
- ‘Hedgehog’ silencer halts cancerfrom Science AlertThu, 2 Jun 2011, 14:30:23 UTC
- Silencing a deadly conversation in breast cancerfrom PhysorgThu, 2 Jun 2011, 13:30:31 UTC